The Patient Journey as Interface: Munich's AI Healthcare Project and the Design of Medical Futures

The questions shaping Europe's AI future won't be answered in press releases alone. They'll be debated, designed, and decided in rooms where policymakers, technologists, and researchers actually meet. One such gathering happens May 19 in Vienna at Human x AI Europe – worth marking if the intersection of governance and implementation matters to the work ahead.

The Interface as Invitation

There is something quietly radical about asking people to choose.

Not to be informed. Not to be reassured. But to stand at a fork in a simulated medical journey and decide: the AI-assisted path, or the one that looks like today.

This is the design logic behind "2036 – Healthy with AI?", a new project from the M1 – Munich Medicine Alliance announced on April 14, 2026. The initiative, funded by Germany's Federal Ministry of Research, Technology and Space (BMFTR) as part of Science Year 2026 – Medicine of the Future, doesn't simply explain what AI might do to healthcare. It builds a digital platform where users navigate five life stages – from genetic analysis in childhood through robotic surgery to assistance systems in old age – choosing between AI-enabled scenarios and their non-AI alternatives.

The project partners include the Technical University of Munich (TUM), LMU Munich, their university hospitals, and Helmholtz Munich. But the content, crucially, will not be defined by these research institutions alone. Two public workshops in April – including one in Munich on April 23 – will bring citizens into the process of identifying and prioritizing which topics matter most.

Notice what's being designed here. Not a lecture. Not a demonstration. An experience of decision-making itself.

The Phenomenology of Choice

Stand in front of a medical interface and notice what happens to attention.

The "patient journey" format – five stages, branching paths, consequences made visible – borrows from interaction design traditions that understand something important: people learn differently when they have agency. When the question isn't "Do you understand?" but "What would you choose?"

The project targets adults aged 40 and older, a demographic that will live through the decade being imagined. These aren't abstract futures for them. They're the years when genetic predispositions become diagnoses, when imaging reveals what was hidden, when the question of who – or what – assists in surgery becomes personal.

The assistant robot Garmi, featured in the project's imagery, represents AI in its most embodied form. But the real interface isn't the robot. It's the moment of choice itself – the pause before clicking, the weighing of benefits against uncertainties, the recognition that these decisions are already being made, somewhere, by someone.

Bavaria's Convergence

The Munich project doesn't exist in isolation. It emerges from a regional ecosystem that has been deliberately constructed over years.

Daniel Rückert, Alexander von Humboldt Professor for AI in Healthcare and Medicine at TUM and recipient of the 2025 Gottfried Wilhelm Leibniz Prize, has been developing federated learning approaches that allow AI models to learn from clinical data across hospitals without the data ever leaving its source. As Research in Bavaria reports, his team adds "noise" to data – a useless portion that makes it impossible for AI to distinguish individual records – combining privacy preservation with distributed learning in ways that are already being applied in MRI and CT systems.

Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Chair of the Bavarian AI Council, leads work on biomedical foundation models trained on over 110 million cells. His lab's Nicheformer model, developed with TUM, integrates single-cell analysis with spatial transcriptomics – the kind of research that makes personalized medicine technically possible rather than merely aspirational.

In January 2026, DLD Munich announced the launch of the Bavarian Health Cloud – a government-supported research data platform designed to consolidate Bavarian health data for AI-driven medical research and personalized care. The announcement came during a BAIOSPHERE Health Track that featured both Rückert and Theis, alongside Bavarian State Ministers Markus Blume and Judith Gerlach.

The convergence is deliberate. Research infrastructure, data governance, public engagement, and political will – all pointing in the same direction.

The European Frame

Bavaria's positioning makes more sense when viewed against the European regulatory landscape taking shape around it.

The European Health Data Space Regulation entered into force on March 26, 2025, establishing the first EU-wide framework for both primary use (direct patient care) and secondary use (research, innovation, policy-making) of electronic health data. Key provisions begin applying in March 2029, with full implementation extending to 2035.

For AI development, the EHDS creates something essential: legal pathways to the data that machine learning requires. Secondary use provisions explicitly include "training, testing and evaluation of algorithms, including in medical devices, in vitro diagnostic medical devices, AI systems and digital health applications." Health Data Access Bodies in each member state will manage access requests, with secure processing environments ensuring data never leaves controlled infrastructure.

The regulatory architecture is complex – the EHDS sits alongside the AI Act, the Medical Devices Regulation, and GDPR – but the direction is clear. Europe is building the governance structures that make large-scale health AI possible while maintaining the privacy protections that make it acceptable.

As Osborne Clarke's analysis notes, the TEHDAS2 joint action is developing the technical specifications that will make Chapter IV of the regulation operational, including requirements for secure processing environments, data catalogues, and fee structures. The second wave of consultations received over 750 responses – evidence of how closely the sector is watching.

What's Being Naturalized

Pay attention to what the Munich project makes visible by making it a choice.

The five life stages – childhood genetic analysis, imaging-based diagnostics, robotic surgery, wearables, assistance systems in old age – aren't random. They trace the points where AI intervention is already technically feasible and increasingly deployed. The question isn't whether these technologies will exist. It's whether their adoption will happen through deliberate public engagement or through the quieter process of institutional default.

The project's partnership with Wort & Bild Verlag, publisher of apotheken-umschau.de (Germany's most-read health publication), ensures distribution beyond academic circles. Five public events across the Munich area will bring researchers into direct conversation with citizens.

This is public engagement as design practice. The artifact – the digital patient journey – becomes a tool for making futures tangible before they arrive.

The Trust Architecture

Helmholtz Munich's AI in Health initiative frames the challenge clearly: "Artificial intelligence is not limited to creating visuals or answering simple questions. It has the exceptional potential to improve human health."

But potential requires trust. And trust requires more than technical capability.

The Munich project explicitly aims to "strengthen trust in AI applications in health care" – not through reassurance but through transparency. By showing both benefits and alternatives, by involving citizens in defining what matters, by making the trade-offs visible rather than hidden, the project treats trust as something that must be earned through design rather than assumed through authority.

This approach reflects a broader European sensibility about technology governance. The AI Act's risk-based framework, the EHDS's opt-out provisions for secondary use, the emphasis on human oversight in high-risk applications – all share an assumption that legitimacy comes from process, not just outcome.

The Decade Ahead

The project's title – "2036 – Healthy with AI?" – frames a ten-year horizon. Long enough for significant change. Short enough to feel real.

What happens in that decade will depend on decisions being made now: about data infrastructure, about regulatory implementation, about public engagement, about the allocation of research funding and clinical attention.

The Munich Medicine Alliance's project is one artifact among many. But it's an artifact that makes something important visible: the future of healthcare isn't something that happens to people. It's something people can participate in shaping – if the interfaces for participation are designed well enough to invite them in.

The question mark in the title isn't rhetorical. It's an actual question, addressed to citizens who will live with the answers.